DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Schmid P, Abraham J, Chan S. et al.
AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.

J Clin Oncol 2018;
36 (Suppl.) Abstr.. 1007

Download Bibliographical Data

Search in:
Access: